Osaic Holdings
LAB icon

Osaic Holdings’s Standard BioTools LAB Stock Holding History

Osaic Holdings’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$866 Hold
943
– – ﹤0.01% 7304
2025
Q4 		$1.21K Hold
943
– – ﹤0.01% 7219
2025
Q3 		$1.22K Hold
943
– – ﹤0.01% 7287
2025
Q2 		$1.13K Buy
943
+65
+7% +$72 ﹤0.01% 7116
2025
Q1 		$948 Buy
878
+285
+48% +$400 ﹤0.01% 6837
2024
Q4 		$1.04K Buy
593
+328
+124% +$611 ﹤0.01% 6833
2024
Q3 		$511 Sell
265
-22,535
-99% -$44.1K ﹤0.01% 7009
2024
Q2 		$40.4K Sell
22,800
-500
-2% -$1.22K ﹤0.01% 4844
2024
Q1 		$63.1K Sell
23,300
-144
-0.6% -$348 ﹤0.01% 4568
2023
Q4 		$51.8K Sell
23,444
-24,136
-51% -$51.5K ﹤0.01% 4884
2023
Q3 		$138K Buy
47,580
+20,355
+75% +$53.2K ﹤0.01% 4263
2023
Q2 		$52.5K Buy
27,225
+43
+0.2% +$85 ﹤0.01% 4910
2023
Q1 		$53K Buy
27,182
+21,690
+395% +$42.9K ﹤0.01% 4909
2022
Q4 		$7K Sell
5,492
-6,936
-56% -$8.54K ﹤0.01% 6128
2022
Q3 		$14K Buy
12,428
+1,720
+16% +$2.6K ﹤0.01% 5828
2022
Q2 		$17K Sell
10,708
-1,969
-16% -$4.87K ﹤0.01% 5722
2022
Q1 		$45K Buy
12,677
+150
+1% +$518 ﹤0.01% 5174
2021
Q4 		$49K Buy
12,527
+518
+4% +$2.42K ﹤0.01% 5163
2021
Q3 		$79K Buy
12,009
+975
+9% +$6.41K ﹤0.01% 4736
2021
Q2 		$68K Sell
11,034
-1,111
-9% -$5.94K ﹤0.01% 4805
2021
Q1 		$55K Buy
12,145
+9,711
+399% +$53.3K ﹤0.01% 4821
2020
Q4 		$15K Buy
2,434
+434
+22% +$2.85K ﹤0.01% 5330
2020
Q3 		$15K Sell
2,000
-602
-23% -$4.16K ﹤0.01% 5072
2020
Q2 		$10K Buy
2,602
+2,593
+28,811% +$9.03K ﹤0.01% 5178
2020
Q1 		$0 Buy
+9
New +$30 ﹤0.01% 6127

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Osaic Holdings's LAB Position: Q1 2026 in Review

Osaic Holdings held its Standard BioTools (LAB) position steady in Q1 2026 at 943 shares worth $866. The position accounts for ﹤0.01% of the portfolio, ranked #7304.

Osaic Holdings first reported a position in LAB in Q1 2020 and has held it in 25 quarters since. The position peaked at $138K in Q3 2023. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Osaic Holdings held 943 shares of Standard BioTools worth $866 as of Q1 2026.
  • Osaic Holdings left its Standard BioTools share count unchanged in Q1 2026.
  • Standard BioTools made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7304 holding.
  • Osaic Holdings first reported a position in Standard BioTools in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Standard BioTools position peaked at $138K in Q3 2023.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.